Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07470775) titled 'Early Dexmedetomidine and Sympathetic Regulation in Sepsis' on March 5.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).

Primary Sponsor: Sichuan Academy of Medical Sciences

Condition: Sepsis Septic Shock

Intervention: Drug: Dexmedetomidine (DEX)

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: March 1, 2026

Target Sample Size: 168

To know more, visit https://clinicaltrials.gov/study/NCT07470775

Published by HT Digital Content Serv...